WGS
GeneDx Holdings Corp.Company Information
- Company Name
- GeneDx Holdings Corp.
- CIK
- CIK0001818331
- Category
- Large accelerated filer
- Ticker: Exchange
- WGS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8000
- SIC Description
- Services-Health Services
- Ticker
- WGS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-05
- Last sale
- 2026-09-16
- Shares purchased (TTM)
- 547,688
- Shares sold (TTM)
- 262,753
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 31,373,402
- Shares outstanding
- 29,710,139
- Ownership
- 105.60%
Earnings Market Reaction
- Filing date
- 2026-08-03
- Price on filing date
- —
- 1-month reaction
- 27.23%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonrelated Party | - | - | - | - | - | - | 37 | 13 | -3 | 28 | 32 | -1 | ||||||
Assets | ||||||||||||||||||
| Related Party | - | - | - | - | - | - | 37 | 13 | -3 | 28 | 32 | -1 | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 60 | 94 | 105 | 96 | 74 | 100 | 85 | 58 | 56 | 84 | 100 | 87 | ||||||
| Marketable Securities Current | 72 | 77 | 66 | 59 | 60 | 59 | 56 | 59 | 51 | 29 | 30 | 27 | ||||||
| Accounts Receivable Net Current | 84 | 77 | 74 | 61 | 48 | 46 | 38 | - | - | - | - | - | ||||||
| Inventory Net | 18 | 12 | 14 | 11 | 12 | 13 | 11 | 11 | 10 | 12 | 9 | 9 | ||||||
| Prepaid Expense And Other Assets Current | 12 | 11 | 9 | 11 | 10 | 8 | 9 | 20 | 19 | 10 | 11 | 16 | ||||||
| Assets Current | 246 | 271 | 268 | 238 | 205 | 226 | 198 | 186 | 162 | 163 | 182 | 172 | ||||||
| Operating Lease Right Of Use Asset | 34 | 35 | 23 | 24 | 25 | 25 | 26 | 25 | 26 | 26 | 27 | 28 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 54 | 50 | 46 | 42 | 40 | 36 | 33 | 31 | 31 | 31 | 32 | 36 | ||||||
| Goodwill | 2 | 2 | 14 | 13 | 13 | - | 0 | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 141 | 145 | 168 | 173 | 177 | 155 | 159 | 162 | 166 | 169 | 173 | 176 | ||||||
| Other Assets Noncurrent | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 6 | ||||||
| Assets | 481 | 506 | 524 | 494 | 464 | 446 | 419 | 409 | 389 | 395 | 419 | 417 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 42 | 47 | 58 | 50 | 49 | 42 | 31 | 56 | 52 | 32 | 37 | 39 | ||||||
| Other Liabilities Current | 27 | 36 | 47 | 33 | 19 | 25 | 20 | - | - | - | - | - | ||||||
| Liabilities Current | 75 | 88 | 109 | 88 | 71 | 70 | 55 | 77 | 68 | 51 | 59 | 68 | ||||||
| Long Term Debt Noncurrent | 97 | 97 | 48 | 52 | 52 | 52 | 52 | 52 | 52 | 52 | 53 | 6 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 2 | 4 | 3 | 7 | 6 | 14 | 13 | 21 | 15 | 23 | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Liabilities | 237 | 252 | 216 | 202 | 187 | 189 | 174 | 204 | 195 | 187 | 191 | 163 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 1,698 | 1,690 | 1,681 | 1,647 | 1,625 | 1,616 | 1,597 | 1,561 | 1,543 | 1,527 | 1,528 | 1,529 | ||||||
| Retained Earnings Accumulated Deficit | -1,455 | -1,437 | -1,373 | -1,356 | -1,348 | -1,359 | -1,352 | -1,358 | -1,350 | -1,320 | -1,300 | -1,274 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | - | ||||||
| Stockholders Equity | 244 | 254 | 308 | 292 | 277 | 257 | 245 | 205 | 194 | 207 | 228 | 254 | ||||||
| Liabilities And Stockholders Equity | 481 | 506 | 524 | 494 | 464 | 446 | 419 | 409 | 389 | 395 | 419 | 417 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||
| Common Stock Shares Issued | 30 | 30 | 29 | 29 | 29 | 29 | 28 | 27 | 27 | 26 | 26 | 26 | ||||||
| Shares Outstanding | 30 | 30 | 29 | 29 | 29 | 29 | 28 | 27 | 27 | 26 | 26 | 26 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGeneDx Holdings Corp. (WGS) — SEC Financial Statements & Analysis
GeneDx Holdings Corp. (WGS) is a services-health services company, incorporated in DE. GeneDx Holdings Corp. trades on Nasdaq as: WGS. GeneDx Holdings Corp. (WGS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03. Based on that filing, GeneDx Holdings Corp. carries a market cap of $2.04B, a P/E ratio of -19.18x, a P/B ratio of 8.35x, a P/S ratio of 4.49x, an enterprise value of $2.08B, and an EV/EBITDA multiple of -31.66x. On profitability, it posts a gross margin of 69.37%, an operating margin of -20.34%, a net margin of -23.40%, a Return on Equity (ROE) of -40.80%, a Return on Assets (ROA) of -22.50%, and a Return on Invested Capital (ROIC) of -33.60%. Per share, it reports EPS of $-3.58, diluted EPS of $-3.58, free cash flow per share of $-2.55, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 25.42% year-over-year, net income growth of -7664.51% year-over-year, and EPS growth of -7376.69% year-over-year. On the balance sheet, it maintains a current ratio of 3.30x, a quick ratio of 2.90x, working capital of $171.73M, a debt-to-equity ratio of 0.97x, a debt ratio of 0.49, an interest coverage ratio of -30.97x, free cash flow of $-75.80M (TTM), and net debt of $35.53M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.04B
- P/E TTM
- -19.18x
- EPS TTM
- $-3.58
- P/B TTM
- 8.35x
- ROE TTM
- -40.80%
- ROA TTM
- -22.50%
- Debt To Equity
- 0.97x
- Free Cash Flow TTM
- $-75.80M
- Net Revenue TTM Growth 1Y
- 25.42%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is GeneDx Holdings Corp. in?
GeneDx Holdings Corp. (WGS) operates in the Services-Health Services industry.
What exchange does WGS trade on?
GeneDx Holdings Corp. (WGS) trades on the Nasdaq.
Where is GeneDx Holdings Corp. incorporated?
GeneDx Holdings Corp. is incorporated in DE.
When was GeneDx Holdings Corp. (WGS)'s most recent SEC filing?
GeneDx Holdings Corp. (WGS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03.
What is WGS's market cap?
GeneDx Holdings Corp. (WGS) has a market capitalization of $2.04B as of 2026-06-30.
What is WGS's EPS (earnings per share)?
GeneDx Holdings Corp. (WGS)'s trailing twelve month EPS is $-3.58 as of 2026-06-30.
What is WGS's ROE (return on equity)?
GeneDx Holdings Corp. (WGS)'s trailing twelve month Return on Equity (ROE) is -40.80% as of 2026-06-30.
What is WGS's ROA (return on assets)?
GeneDx Holdings Corp. (WGS)'s trailing twelve month Return on Assets (ROA) is -22.50% as of 2026-06-30.
What is WGS's ROIC (return on invested capital)?
GeneDx Holdings Corp. (WGS)'s trailing twelve month Return on Invested Capital (ROIC) is -33.60% as of 2026-06-30.
What is WGS's EV/EBITDA?
GeneDx Holdings Corp. (WGS)'s trailing twelve month EV/EBITDA is -31.66x as of 2026-06-30.